Terms: = Lymphoma AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1 AND Treatment
10 results:
1. Clinical Features and Genetic Analysis of Taiwanese Primary Immunodeficiency Patients with Prolonged Diarrhea and Monogenetic Inflammatory Bowel Disease.
Lee WI; Chen CC; Chen SH; Lai WT; Jaing TH; Ou LS; Liang CJ; Kang CC; Huang JL
J Clin Immunol; 2023 Aug; 43(6):1455-1467. PubMed ID: 37202577
[TBL] [Abstract] [Full Text] [Related]
2. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
[TBL] [Abstract] [Full Text] [Related]
3. Resistance of B-Cell lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation.
Laurent C; Syrykh C; Hamon M; Adélaïde J; Guille A; Escudié F; Jalowicki G; Fina F; Bardet A; Mescam L; Molina TJ; Dartigues P; Parrens M; Sujobert P; Besson C; Birnbaum D; Xerri L
Am J Surg Pathol; 2022 Jun; 46(6):742-753. PubMed ID: 34799485
[TBL] [Abstract] [Full Text] [Related]
4. Increased activation of PI3 kinase-δ predisposes to B-cell lymphoma.
Durandy A; Kracker S
Blood; 2020 Feb; 135(9):638-643. PubMed ID: 31942637
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.
Elkaim E; Neven B; Bruneau J; Mitsui-Sekinaka K; Stanislas A; Heurtier L; Lucas CL; Matthews H; Deau MC; Sharapova S; Curtis J; Reichenbach J; Glastre C; Parry DA; Arumugakani G; McDermott E; Kilic SS; Yamashita M; Moshous D; Lamrini H; Otremba B; Gennery A; Coulter T; Quinti I; Stephan JL; Lougaris V; Brodszki N; Barlogis V; Asano T; Galicier L; Boutboul D; Nonoyama S; Cant A; Imai K; Picard C; Nejentsev S; Molina TJ; Lenardo M; Savic S; Cavazzana M; Fischer A; Durandy A; Kracker S
J Allergy Clin Immunol; 2016 Jul; 138(1):210-218.e9. PubMed ID: 27221134
[TBL] [Abstract] [Full Text] [Related]
7. Advances in basic and clinical immunology in 2014.
Chinen J; Notarangelo LD; Shearer WT
J Allergy Clin Immunol; 2015 May; 135(5):1132-41. PubMed ID: 25956014
[TBL] [Abstract] [Full Text] [Related]
8. Atypical fibroxanthoma: a series of 25 cases.
Wollina U; Schönlebe J; Koch A; Haroske G
J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):943-6. PubMed ID: 20158588
[TBL] [Abstract] [Full Text] [Related]
9. Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.
Kharas MG; Janes MR; Scarfone VM; Lilly MB; Knight ZA; Shokat KM; Fruman DA
J Clin Invest; 2008 Sep; 118(9):3038-50. PubMed ID: 18704194
[TBL] [Abstract] [Full Text] [Related]
10. Immunocytochemical detection of phosphatidylinositol 3 kinase in Burkitt lymphoma cells.
Miscia S; di Baldassarre A; Rana RA; Pucci AM; Cataldi A
Cell Struct Funct; 1998 Feb; 23(1):17-22. PubMed ID: 9639026
[TBL] [Abstract] [Full Text] [Related]
